Ashby Smith Email & Phone Number

Washington, DC, US

Paris, France, FR

• Specialty Immunology Business Unit - Responsible for the promotion of Dupixent (dupilumab) to allergists and ENTs
• Championed the promotion of Dupixent to Allergists and ENTs, achieving top-third national ranking Q1 and Q2 2024 for moderate-to-severe asthma and chronic rhinosinusitis with nasal polyposis
• U.S. Public Affairs and Patient Advocacy COPD Patient Engagement and Activation GIG August 2024-December 2024
• U.S. Public Affairs and Patient Advocacy Health Equity GIG August 2023-February 2024
• NJ Region Representative for Marketing Advisory Board 2024Initiations Contest Winner:
• 2023 Year-Long Contest: February, March, July, December

Brentford, Middlesex, GB

• Specialty Respiratory Business Unit - Responsible for the promotion of Nucala (mepolizumab), a buy and bill biologic, to pulmonologists, allergists, ENTs and pediatricians.
• Promoted Nucala to pulmonologists, allergists and ENTs for four primary eosinophilic driven diseases including severe eosinophilic asthma (SEA), hyper eosinophilic syndrome (HES), chronic rhinosinusitis withnasal.
• Executed sales for Q1 2022 102% to plan, Q2 2022 99% to plan, Q3 99.6% to plan and Q4 98% to plan
• Coordinated with Strategic Account Leads (SALs) in identifying hospital key decision makers to encourage large non-retail purchases of Nucala at major hospital institutions including Montefiore, NYC Health Hospitals.

Brentford, Middlesex, GB

• Respiratory Business Unit - Promoted the company’s respiratory portfolio, specifically Anoro (umeclidinium-vilanterol) and Trelegy (fluticasone furoate-umeclidinium-vilanterol), to pulmonologists and primary care.
• Promoted GSK Elipta portfolio of Trelegy, Anoro and Breo for asthma and COPD receiving Northeast regional recognition for market share attainmentQ4 2019, Q1 2020
• Launched Trelegy’s asthma indication and maintained 100%-to-goal or above performance for net-to-market business over four consecutive quarters
• Pioneered access and established long-standing relationships in pivotal limited access spaces including Montefiore Hospital System, New York Presbyterian Hospital System, NYC Health+ (Jacobi, Lincoln)
• District representative for the Anoro Regional Team 2019-2020
• District representative for the Regional Payer Market Liaison Team 2019-2021

Cranbury, New Jersey, US

• Respiratory Business Unit - Under contract for AstraZeneca to promote Symbicort (budesonide-formoterol) and Bevespi (glycopyrrolate-formoterol) to pulmonologists and primary care physicians.
• Contracted for AstraZeneca to drive the promotion of Symbicort and Bevespi for AstraZeneca, successfully managing territory and preparing for Breztri launch.

Indianapolis, Indiana, US

• Diabetes Business Unit - Responsible for promoting Trulicity (P1), Basaglar, and Jardiance (P2) to primary care physicians, internal medicine doctors and limited specialists as well as calls on pharmacists.
• Promoted the full company diabetes oral and injectable portfolio including Tradjenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trulicity, Basaglar and Humalog to primary care physicians and pharmacists
• Received Regional recognition for Basaglar attainment at 110%
• Led the promotion of the diabetes portfolio, achieving 105% to plan EOY for position 1 product, 100% for 8 product portfolio
• Enhanced prescribing practices of no-access HCPs through strategic direct-to-customer resource utilization, expanding market penetration.
• Established healthy team ways-of-working to co-promote portfolio alongside a direct Eli Lilly and Boehringer Ingelheim counterpart

Morrisville, NC, US

• Specialty Business Unit - Under contract for Celgene to promote Otezla (apremilast) to dermatologists and rheumatologists.
• Targeted primary care physicians, dermatologists and rheumatologists on Otezla under contract for for Celgene’s Otezla, achieving quotas through effective virtual and telephonic engagement.
• Executed details and sample orchestration for no-access doctors with perfect assessments on all monitored calls.

Hershey, Pennsylvania, US

• Managed a $6 million territory, achieving year-over-year POS growth for major accounts and the highest peak season sales in territory history.
• Delivered positive year over year POS growth for major accounts Walmart (+2.5%), Wakefern (+2.5%), and Acme (+5.9%) with the highest peak season (October) in territory-history
• Worked with key decision makers (KDMs) to create and execute store merchandising plans in line with weekly sales opportunities for customers
• Liaised between team and account management for Acme Corporation as Acme Brand Lead for New Jersey district

New York, US

Processed trades ensuring that they were compliant with federal regulations.

New Brunswick, New Jersey, US

• Raised and confirmed over two hundred thousand dollars in scholarship funds through cold calls, hiring and mentoring new employees, and collaborating on public relations strategies.
• Part of the caller team responsible for helping Rutgers raise $1,037,056,700 in funds for the ‘Our Rutgers, Our Future’ campaign.

Served as campus security as a student working in tandem with University Police to ensure safety at Rutgers was maintained.

Master Of Public Health - Mph, Urban Health

Bachelor Of Arts - Ba, Political Science And Government

High School Diploma

High School Diploma